S.A. Mason’s Acutus Medical Inc AFIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,000
Closed -$4 369
2025
Q2
$4 Hold
2,000
﹤0.01% 362
2025
Q1
$85 Sell
2,000
-1,000
-33% -$43 ﹤0.01% 348
2024
Q4
$165 Hold
3,000
﹤0.01% 342
2024
Q3
$252 Sell
3,000
-3,400
-53% -$286 ﹤0.01% 324
2024
Q2
$227 Hold
6,400
﹤0.01% 318
2024
Q1
$1.2K Hold
6,400
﹤0.01% 311
2023
Q4
$1.29K Hold
6,400
﹤0.01% 312
2023
Q3
$4.46K Hold
6,400
﹤0.01% 304
2023
Q2
$4.83K Hold
6,400
﹤0.01% 306
2023
Q1
$4.83K Hold
6,400
﹤0.01% 306
2022
Q4
$7.36K Sell
6,400
-1,700
-21% -$1.4K 0.01% 296
2022
Q3
$7K Hold
8,100
0.01% 307
2022
Q2
$9K Hold
8,100
0.01% 309
2022
Q1
$11K Hold
8,100
0.01% 312
2021
Q4
$28K Sell
8,100
-6,200
-43% -$34.9K 0.02% 284
2021
Q3
$126K Buy
+14,300
New +$188K 0.08% 182

S.A. Mason's AFIB Position: Q3 2025 in Review

S.A. Mason sold out of Acutus Medical Inc (AFIB) in Q3 2025, closing a stake of 2,000 shares — an estimated $4 sold.

S.A. Mason first reported a position in AFIB in Q3 2021 and held it in 16 quarters. The position peaked at $126K in Q3 2021. 0 funds tracked by Wall St. Rank hold AFIB as of Q3 2025.

  • S.A. Mason reported no remaining Acutus Medical Inc position as of Q3 2025 after selling out during the quarter.
  • S.A. Mason sold 2,000 Acutus Medical Inc shares in Q3 2025, an estimated $4.
  • S.A. Mason first reported a position in Acutus Medical Inc in Q3 2021 and held it in 16 quarters.
  • S.A. Mason's Acutus Medical Inc position peaked at $126K in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q3 2025.

Based on S.A. Mason's 13F filing for Q3 2025, filed 14 Oct 2025.